STOCK TITAN

TELA Bio to Participate in Upcoming Canaccord Genuity Musculoskeletal Conference in Chicago, IL

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

TELA Bio, Inc. (NASDAQ: TELA) announced its participation in the Canaccord Genuity Musculoskeletal Conference to be held on March 22, 2022, in Chicago, IL. The company aims to provide innovative soft-tissue reconstruction solutions that enhance clinical outcomes by preserving patients’ anatomy. Management will present at 3:30 PM CT, and a live and archived webcast will be accessible via their investor relations site. TELA Bio focuses on economically effective technologies that leverage natural healing responses while reducing reliance on synthetic materials.

Positive
  • None.
Negative
  • None.

MALVERN, Pa., March 16, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy, today announced that the Company will participate in the Canaccord Geunity Musculoskeletal Conference on March 22, 2022 in Chicago, IL.

TELA Bio’s management is scheduled to present at the 2022 Canaccord Genuity Musculoskeletal Conference on Tuesday, March 22, 2022 at 3:30pm CT.  Interested parties can access the live and archived webcast at ir.telabio.com.

About TELA Bio, Inc.

TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient’s natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.

Investor Contact
Greg Chodaczek
332-895-3230
ir@telabio.com


FAQ

When is TELA Bio presenting at the Canaccord Genuity Musculoskeletal Conference?

TELA Bio will present on March 22, 2022, at 3:30 PM CT.

Where can I access the webcast of TELA Bio's conference presentation?

The live and archived webcast can be accessed at ir.telabio.com.

What is the focus of TELA Bio as a company?

TELA Bio focuses on innovative soft-tissue reconstruction solutions that prioritize the preservation and restoration of the patient’s anatomy.

What is the stock symbol for TELA Bio?

The stock symbol for TELA Bio is TELA, and it is listed on NASDAQ.

Where is the Canaccord Genuity Musculoskeletal Conference taking place?

The conference is being held in Chicago, IL.

TELA Bio, Inc.

NASDAQ:TELA

TELA Rankings

TELA Latest News

TELA Stock Data

113.83M
34.43M
4.49%
51.75%
1.22%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
MALVERN